Chad Thomas Campbell - Oct 5, 2021 Form 4 Insider Report for ANGIODYNAMICS INC (ANGO)

Role
SVP/GM, Vascular Access
Signature
/s/ Richard C. Rosenzweig, Attorney in Fact
Stock symbol
ANGO
Transactions as of
Oct 5, 2021
Transactions value $
-$113,499
Form type
4
Date filed
10/6/2021, 06:39 PM
Previous filing
Aug 18, 2021
Next filing
Jul 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANGO Common Stock Options Exercise $178K +10.7K +33.86% $16.59 42.5K Oct 5, 2021 Direct
transaction ANGO Common Stock Sale -$292K -10.7K -25.3% $27.15 31.7K Oct 5, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANGO Non-Qualified Stock Option (right to buy) Options Exercise $0 -10.7K -100% $0.00* 0 Oct 5, 2021 Common Stock 10.7K $16.59 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.07 to $27.35, inclusive. The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1.
F2 Options for one-fourth of the shares became exercisable on 7/27/2017, 7/27/2018, 7/27/2019 and 7/27/2020, respectively.